Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study
BackgroundConventional clinical trials are essential for generating high-quality evidence by measuring the efficacy of interventions in rigorously controlled clinical environments. However, their execution can be expensive and time-consuming. In addition, clinical trials face...
Main Authors: | Romée Melanie Helena Coert, James Kenneth Timmis, André Boorsma, Wilrike J Pasman |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-07-01
|
Series: | Journal of Medical Internet Research |
Online Access: | https://www.jmir.org/2021/7/e26813 |
Similar Items
-
Effects of a 13-Week Personalized Lifestyle Intervention Based on the Diabetes Subtype for People with Newly Diagnosed Type 2 Diabetes
by: Iris M. de Hoogh, et al.
Published: (2022-03-01) -
Stakeholders barriers and facilitators for the implementation of a personalised digital care pathway: a qualitative study
by: Margriet Mullender, et al.
Published: (2022-11-01) -
PROTOCOL: Barriers and facilitators to stakeholder engagement in health guideline development: A qualitative evidence synthesis
by: Olivia Magwood, et al.
Published: (2022-06-01) -
Stakeholder Power Analysis of the Facilitators and Barriers for Telehealth Solution Implementation in China: A Qualitative Study of Individual Users in Beijing and Interviews With Institutional Stakeholders
by: Nuoya Chen
Published: (2022-01-01) -
Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States
by: Monica M. Schroll, et al.
Published: (2022-06-01)